Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Apart in Adults Aged 60 Years and Older in Stable Health

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02926430
Recruitment Status : Completed
First Posted : October 6, 2016
Last Update Posted : February 19, 2019
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 14, 2018
Actual Study Completion Date : January 29, 2019